Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
61 - 64 of 64 search results for news |u:mitocamb.medschl.cam.ac.uk

  1. Fully-matching results

  2. [11C]PK11195 PET as a biomarker to diagnose and monitor natural…

    https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/measuring-studies/11cpk11195-pet-as-a-biomarker-to-diagnose-and-monitor-natural-history-in-mitochondrial-disease/
    23 Feb 2024: Loading. Menu. Menu. Search. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease. Status: Open to

  3. Understanding the progression over time of hereditary spastic…

    https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/understanding-studies/understanding-the-progression-over-time-of-hereditary-spastic-paraplegia-hsp-ataxia-and-related-conditions-prospax/
    23 Feb 2024: Loading. Menu. Menu. Search. Understanding the progression over time of hereditary spastic paraplegia (HSP), ataxia and related conditions (PROSPAX). Understanding the progression over time of hereditary spastic paraplegia (HSP), ataxia and related

  4. DefINe: A randomised, double-blind, placebo-controlled trial…

    https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/define-a-randomised-double-blind-placebo-controlled-trial-examining-the-safety-and-efficacy-of-deferiprone-in-patients-with-neuroferritinopathy/
    23 Feb 2024: Loading. Menu. Menu. Search. DefINe: A randomised, double-blind, placebo-controlled trial examining the safety and efficacy of deferiprone in patients with neuroferritinopathy. DefINe: A randomised, double-blind, placebo-controlled trial examining

  5. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense…

    https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/osprey-study-a-phase-i-open-label-study-to-investigate-antisense-oligonucleotide-stk-002-in-patients-with-adoa/
    23 Feb 2024: Loading. Menu. Menu. Search. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense Oligonucleotide STK-002 in Patients with ADOA. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense Oligonucleotide STK-002 in Patients

Refine your results

clear all

Date

Related searches for news |u:mitocamb.medschl.cam.ac.uk

By type

By topic

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.